Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-400-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- other: expert statement
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: An extended assessment of the toxicokinetic behaviour of MnGHA was performed, taking into account the chemical structure, the available physico-chemical-data and the available toxicity data.
Data source
Reference
- Reference Type:
- other: Toxicokinetic statement
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Series on Testing and Assessment No. 29 (23-Jul-2001): Guidance document on transformation/dissolution of metals and metal compounds in aqueous media
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: TGD, Part I, Annex IV, 2003); ECHA guidance R7c., 2012
- Deviations:
- no
- Principles of method if other than guideline:
- An assessment of toxicological behaviour of MnGHA is based on its physico-chemical properties and on the results of available toxicity data data.
- GLP compliance:
- no
Test material
- Reference substance name:
- Reaction products of sodium glucoheptonate with manganese sulfate and sodium hydroxide
- EC Number:
- 946-400-7
- Molecular formula:
- Not specified (UVCB substance).Molecular formula of the main substance:C14H30O22SMn2
- IUPAC Name:
- Reaction products of sodium glucoheptonate with manganese sulfate and sodium hydroxide
Constituent 1
Results and discussion
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- GI absorption of 100 % and 3-5 % for the chelating agent GHA and free manganese, respectively, are considered. Dermal absorption is very low and absorption via inhalation is confined to the amount deposited in upper airways which can be swallowed.
- Type:
- distribution
- Results:
- Distribution of dissociation products absorbed from the gastrointestinal tract is expected to be extensive throughout the body. However, no wide distribution is expected in case of dermal or inhalation exposure.
- Type:
- excretion
- Results:
- The released free GHA and manganese are expected to be excreted mainly via the urine or faeces, respectively. Small amounts of manganese can be excreted via the urine. Biliary excretion was also observed for glucoheptonate.
- Type:
- metabolism
- Results:
- Glucoheptonate is involved into intermediary carbohydrate metabolism. Mn may undergo changes in oxidation state within the body: from Mn (II) to Mn (III), but the formation of complexes with biomolecules is also possible:bile salts, proteins, nucleotids.
Applicant's summary and conclusion
- Conclusions:
- The substance will be limted absorbed following inhalation exposure due to its very low vapour pressure (12.75 x 10E-5 Pa) and microgranulated form. Dermal absorption is considered to be negligible. In case of oral route of exposure the substance will dissociate under acidic conditions releasing free GHA and manganese, which are expected be readily absorbed, wide distributed and not extensively metabolised in the body. Excretion will be primarily via the faeces and via the urine, in case of manganese and glucoheptonate, respectively.
No bioaccumulation potential is expected. - Executive summary:
Manganese glucoheptonate is expected to be moderately absorbed after oral exposure, based on its high water solubility and molecular weight suggestive for favoured absorption through gastrointestinal tract. As worst-case, 100 % oral absorption is considered appropriate for the complex whereby only limited absorption (5 %) is determined for manganese. Concerning absorption after exposure via inhalation, as the chemical has a low vapour pressure, is highly hydrophilic, has a negative LogPow, and has 11.47 % of particles less than 100 µm, it is clear, that the substance is poorly available for inhalation and will not be absorbed significantly via lungs. However, an absorption by aspiration cannot be fully ruled out. Therefore, 100% inhalation absorption is considered. Manganese glucoheptonate is not expected to be absorbed following dermal exposure into the stratum corneum and into the epidermis, due to its very high water solubility and considering low absorption potential of manganese and glucoheptonate moieties. 10 % absorption is therefore considered for dermal route of exposure. The glucoheptonate moieties or as complex with manganese are expected to be distributed predominantly to kidneys and organs with higher expression of glucose transporters. Manganese is distributed predominantly to brain, liver, pancreas, and kidney. The substance does not indicate a significant potential for accumulation. Manganese homeostasis is regulated in mammals by gastrointestinal absorption, excretion via faeces and via the urine as well as by the release from tissues. The total body manganese is maintained constant at the physiologically required levels of manganese in the various tissues at low and high dietary manganese intakes. Manganese, if released from glucoheptonate, is distributed to all organs and tissues and will be bound with organic ligands rather than existing free in solution as a cation. Manganese is excreted mainly via the faeces. Glucoheptonate is involved into intermediary carbohydrate metabolism and eliminated unchanged primarily via the urine and to a lesser extent via the bile.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.